Daewoong Co., Ltd.

KSE 003090.KS

Daewoong Co., Ltd. Capital Expenditure for the year ending December 31, 2023: USD -175.84 M

Daewoong Co., Ltd. Capital Expenditure is USD -175.84 M for the year ending December 31, 2023, a -89.23% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).

Daewoong Co., Ltd. Capital Expenditure for the year ending December 31, 2022 was USD -92.92 M, a 3.89% change year over year.
Daewoong Co., Ltd. Capital Expenditure for the year ending December 31, 2021 was USD -96.68 M, a -61.81% change year over year.
Daewoong Co., Ltd. Capital Expenditure for the year ending December 31, 2020 was USD -59.75 M, a -1.38% change year over year.
Daewoong Co., Ltd. Capital Expenditure for the year ending December 31, 2019 was USD -58.94 M, a 1.72% change year over year.

Key data

Date	Capital Expenditure	Free Cash Flow	Depreciation And Amortization	Deferred Income Tax

KSE: 003090.KS

Daewoong Co., Ltd.

CEO	Mr. Yeong-Hwan Yoon
IPO Date	Jan. 4, 2000
Location	South Korea
Headquarters	35-14, Jajanggongdan 4-gil
Employees	353
Sector	Healthcare
Industries Pharmaceuticals Drugstores & Retail Pharmacies Eyewear

Description

Daewoong Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceuticals. It also engages in the leasing of real estates. The company was formerly known as Daewoong Pharmaceutical Co., Ltd. and changed its name to Daewoong Co., Ltd. in 2002. Daewoong Co., Ltd. was founded in 1961 and is headquartered in Seongnam-si, South Korea.

Key trends

Past 5 years